Komodo Health

Komodo Health maps 330M+ de-identified patient journeys by linking claims, lab, genomics, and demographic data, powering real-world evidence analytics for life sciences and providers. Databricks Healthcare & Life Sciences Partner of the Year 2025. 330M+ patient journeys mapped. Named among top health tech companies. Platform used across pharma, consultancies, and government.

Komodo's Healthcare Map is the most comprehensive patient-journey dataset outside of a payer; its Databricks Partnership of the Year 2025 recognition signals it is becoming the real-world data standard for life sciences AI.

komodohealth.com Interoperability & Data Infrastructure

United Statesprivate

At a glance

Total raised

$534M

last round convertible

Headcount

—

no public estimate on record

Headquarters

San Francisco

United States

Founded

2014

12 years active

Status

Private

Interoperability & Data Infrastructure

Subsector

Interoperability & Data Infrastructure

For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Founding

50% off

/month

94 of 100 spots left

Full

$10

/month

Available once all 100 Founding Member spots are claimed.

Get full access

Already subscribed? Sign in →

Funding history

Total raised

$534M

Rounds tracked

Latest stage

Convertible

Date	Stage	Amount	Valuation	Lead investors
Nov 1, 2022	Convertible	$200M	—	Coatue, Dragoneer Investment Group
Mar 22, 2021	Series E	$220M	$3.3B	Tiger Global Management, Casdin Capital
Jan 12, 2021	Series D	$44M	—	—
Jan 8, 2020	Series C	$50M	—	Andreessen Horowitz
Jun 12, 2018	Series B	$20M	—	—
Jan 1, 2016	Series A	—	—	McKesson Ventures

Founder backgrounds

Arif Nathoo

Co-Founder & CEO

Trained as a physician and policy specialist, Nathoo earned an M.D. from Harvard Medical School and an M.P.A. in health policy from the Harvard Kennedy School, following an A.M. in molecular and cellular biology from Harvard College (magna cum laude). Before co-founding Komodo Health in 2014, he spent roughly six years at McKinsey & Company, rising to Associate Principal and co-leading the firm's medical affairs practice — work that gave him direct exposure to how fragmented healthcare data frustrates life-sciences decision-making. That consulting experience, combined with his clinical training, shaped Komodo's thesis: unify claims, lab, genomic, and demographic records into a single patient-journey map. The company has raised over $400 million and reached a valuation above $3 billion.

Web Sun

Co-Founder & President

Co-founded Komodo Health alongside Arif Nathoo after spending a decade in life sciences advisory and data roles. Previously a managing director at Zephyr Health, a life sciences data and insights platform, where he ran all non-engineering functions. Before that, spent nearly eight years as a vice president at Campbell Alliance (now Syneos Health), advising enterprise life sciences companies on corporate development, brand management, and commercial strategy. Holds an MBA in marketing, finance, and international business from NYU Stern. That blend of strategic advisory and commercial data experience — understanding both how life sciences companies buy insights and where existing analytics fell short — directly shaped Komodo’s product thesis: stitching fragmented claims, lab, and genomics data into a unified patient journey map rather than selling more point-solution reports.

AI bull / bear

Bull case

Komodo Health sits on an asset that gets harder to replicate with every passing year: 330 million de-identified patient journeys stitched across claims, labs, genomics, and demographics. No startup can recreate that breadth from scratch, and even large payers rarely integrate across the silos Komodo bridges. The 2025 Databricks Healthcare & Life Sciences Partner of the Year award signals something bigger than a vendor relationship — it positions Komodo as the default real-world data layer for the life sciences AI stack, where modeling drug efficacy, patient stratification, and post-market surveillance increasingly run on Databricks infrastructure. With $534 million in backing from Coatue and Dragoneer, Komodo has the capital runway to convert its data advantage into workflow embedding across pharma, consultancies, and government. As FDA and EMA guidance tilts toward real-world evidence for label expansions and accelerated approvals, Komodo's map becomes not just useful but mandatory.

Bear case

Komodo last raised money in November 2022 — a $200 million convertible note, not a priced equity round. Two and a half years without fresh funding is a long silence for a capital-intensive data business that must continuously ingest, clean, and link new data streams just to maintain its 330-million-journey asset. Convertible notes from crossover funds like Coatue and Dragoneer often embed aggressive terms; if Komodo's valuation has not grown meaningfully since 2022, conversion could trigger messy dilution or a down-round signal that spooks enterprise buyers. Meanwhile, UnitedHealth's Optum already owns the raw claims on a vast portion of American lives and is building its own analytics franchise — vertically integrated and answerable to no third-party data licensor. IQVIA, Flatiron, and TriNetX all compete for the same pharma RWE budgets. Without a clear path to IPO or strategic exit, Komodo risks being a rich dataset in search of a defensible business model.

Generated by deepseek-v4-pro · May 2, 2026Refreshes quarterly · see disclosures

In the news

Komodo Health · last 30 days

No articles ingested yet for Komodo Health. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.

Watch

Leadership

Arif Nathoo

Co-Founder & CEO

—

Web Sun

Co-Founder & President

—

Amit Sangani

Chief Technology Officer

—

Paul Gurney

Chief Product Officer

—

Mark Jewett

Chief Marketing Officer

—

Sarah Shin

Chief People Officer

—

Products

Healthcare Map
Komodo's foundational data asset that tracks over 330 million de-identified patient journeys across the U.S. by linking claims, clinical, lab, genomics, pharmacy, and social determinants of health data. It provides longitudinal, patient-level insights that eliminate data silos and bias, giving life sciences, providers, and government organizations a complete view of healthcare encounters across all care settings.
Marmot
A healthcare-native AI analytics platform purpose-built on the Healthcare Map. Marmot delivers reproducible, traceable, and governed AI insights that accelerate healthcare innovation for life sciences and provider organizations. Unlike generic AI models, it is trained on the industry's most authoritative real-world patient data, enabling users to run complex analyses, generate evidence, and derive actionable intelligence with full transparency and defensibility.
Komodo Home
A unified analytics workspace that centralizes the workflow for life sciences and healthcare teams. Users can ask questions, build analyses, and run queries against Komodo's real-world data all in one environment, streamlining the journey from data exploration to insight generation without switching between disparate tools and platforms.
MapEnhance
An AI-powered data enrichment offering that integrates with Cornerstone AI to clean, standardize, and enhance raw healthcare data before it enters the Komodo platform. MapEnhance improves the accuracy and volume of real-world insights by automating data cleansing at scale, ensuring that downstream analytics and AI models operate on the highest-fidelity data possible.

Open roles

View all careers ↗